Dominion Energy Inc vs Merck & Co., Inc. — how do they compare? Dominion Energy Inc trades at $70.9 (market cap $62.71B), while Merck & Co., Inc. trades at $123.39 (market cap $298.31B). The key difference: Merck & Co., Inc. is far larger — about 4.8× Dominion Energy Inc's market cap, and Dominion Energy Inc pays the higher dividend (3.74%). Which is the better fit depends on your goals.
| D | MRK | |
|---|---|---|
Market Cap | $62.71B | $298.31B |
Sector | Utilities | Health |
52-Week High | $71.32 | $129.52 |
52-Week Low | $56.55 | $77.60 |
Enterprise Value | $115.11B | $341.72B |
Dividend Yield | 3.74% | 2.82% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Merck (MRK) trades at $123.43, down 0.48% on the day, with a bullish technical signal and strong institutional buying. Recent earnings beat expectations in three of the last four quarters, with Q2 2026 results pending. The company's acquisition of Terns Pharmaceuticals for approximately $6.7 billion aims to bolster its oncology pipeline, while solid profitability metrics include a net income margin of 13.59% and ROE of 18.97% for 2025.
The outlook remains positive with a consensus price target of $137.30, implying 11% upside. Key risks include rising debt levels and competitive pressures in the pharmaceutical sector. Analysts are predominantly bullish, with 68% recommending Buy, supported by robust cash flow and strategic M&A activity to drive long-term growth.
Trailing returns across standard periods
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →